Back to Rankings

IEX

IDEXC
NYSE / Capital Goods
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
25%
Probability
Target price
$232.00
+9.4% vs current
Most likely
B
Base case
50%
Probability
Target price
$220.00
+3.7% vs current
B-
Bear case
25%
Probability
Target price
$188.00
-11.4% vs current

AI sentiment snapshot

Latest data as of 2026-04-29
Recent news sentiment (30D)
+0.5
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+50.2
Score

AI commentary

Headline buzz is high because this is an earnings-day follow-up. Price action was positive but not extreme: IEX traded about 4.9% above the $205.36 anchor on April 29 and below the session high of $224.99. Trusted secondary coverage indicated a meaningful EPS and revenue beat, but T+1 analyst target/rating revision evidence was still sparse, so this remains a moderate-confidence post-earnings monitoring memo rather than a full thesis reset.

RankAlpha Sentiment Codex - 2026-04-29
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-04-29eventQ1 beat with raised 2026 guidanceMedium impact

IDEX reported Q1 sales of $886.9M (+9% reported, +5% organic), adjusted EPS of $2.00, record orders of $988.3M (+13% reported, +10% organic), and raised full-year organic growth guidance to 3%-4% from 1%-2% and adjusted EPS to $8.35-$8.55 from $8.15-$8.35 [#8-K-2026-04-29].

2026-05-15catalystPost-print digestion still has room but revision evidence is thinMedium impact

The stock traded at $215.49 on April 29, 2026 versus a $205.36 prior close anchor, a roughly 4.9% gain, while the packet's median analyst target is $226.08; that leaves modest upside if follow-through revisions arrive, but T+1 target/rating changes were not yet clearly available.

2026-09-30catalystHST demand and order momentum can extend the re-rateHigh impact

Health & Science Technologies grew 17% reported and 11% organically, driven by AI-linked data center power, semiconductor, and space/defense demand, while management said 8020 execution is reallocating resources toward stronger growth and margin opportunities [#8-K-2026-04-29] [#10-K-2026-02-19].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-04-29 • Updated nightlySource: Internal modelMethodology